Aquaculture Europe 2013 will take place in Trondheim, Norway, on August 9, and animal health company Novus will be present to support the international industry conference. The theme of this year's event is "Making Sense of Science."
"Novus is firmly committed to supporting the aquaculture industry, which continues to experience tremendous growth," said Dr. Francisco Gomes, executive manager of Novus Aqua. "Novus embraces every opportunity it has to share the scientific research and information that is the foundation for the development of products and solutions that maximize efficiency and profitability at every stage in the aquaculture production chain.
"We're continually focusing on the needs of the animal and the understanding of our customer's value chain. We have invested extensive resources in the European marine fish industry. Through strategic partnerships with customers and research partners we have been able to achieve significant milestones in issues such as sea lice, myxosporidia and enteritis," Gomes added.
Craig Browdy, executive manager of aquaculture research at Novus, will be presenting a scientific abstract on August 10. Entitled, "Mode of Action and Practical Applications of the Prebiotic Previda to Improve Fish Health," the abstract will discuss the results of a series of in vitro, in vivo and ex vivo field and lab tests with Previda.
In the research, Previda binded with bacterial binding receptors, which left them inaccessible to pathogens, encouraged selective fermentation, which allowed beneficial bacteria to completely exclude pathogens, and caused significant improvements in gut ultrastructure. These benefits resulted in a reduction of enteritis and improvement in performance in sensitive marine species.
Previda is a single-source material which has a consistent composition and is of 100 percent natural origin with no added chemicals. Introduced by Novus in 2011, the prebiotic won the 2012 North American New Product Innovation Award for Prebiotics.
"Novus is firmly committed to supporting the aquaculture industry, which continues to experience tremendous growth," said Dr. Francisco Gomes, executive manager of Novus Aqua. "Novus embraces every opportunity it has to share the scientific research and information that is the foundation for the development of products and solutions that maximize efficiency and profitability at every stage in the aquaculture production chain.
"We're continually focusing on the needs of the animal and the understanding of our customer's value chain. We have invested extensive resources in the European marine fish industry. Through strategic partnerships with customers and research partners we have been able to achieve significant milestones in issues such as sea lice, myxosporidia and enteritis," Gomes added.
Craig Browdy, executive manager of aquaculture research at Novus, will be presenting a scientific abstract on August 10. Entitled, "Mode of Action and Practical Applications of the Prebiotic Previda to Improve Fish Health," the abstract will discuss the results of a series of in vitro, in vivo and ex vivo field and lab tests with Previda.
In the research, Previda binded with bacterial binding receptors, which left them inaccessible to pathogens, encouraged selective fermentation, which allowed beneficial bacteria to completely exclude pathogens, and caused significant improvements in gut ultrastructure. These benefits resulted in a reduction of enteritis and improvement in performance in sensitive marine species.
Previda is a single-source material which has a consistent composition and is of 100 percent natural origin with no added chemicals. Introduced by Novus in 2011, the prebiotic won the 2012 North American New Product Innovation Award for Prebiotics.
No comments:
Post a Comment